The one-step inoculation procedure makes RapID the easiest ID system to use. With results in just 4 hours, it?s the fastest and most convenient ID system in its class, with the potential to save time, labour and money.
The one-step inoculation procedure makes RapID the easiest ID system to use. With results in just 4 hours, it’s the fastest and most convenient ID system in its class, with the potential to save time, labour and money.
Unlike other methods that require separate inoculation of individual wells, RapID has a simple, one-step inoculation procedure. A colony suspension is simply added to the inoculation tray and tipped into the test strip, inoculating each well simultaneously. Each panel uses the same simple procedure, so if you can use one RapID panel, you can use them all.
RapID provides rapid, same-day results (unlike alternative methods that require 18-72 hours). The system detects preformed bacterial enzymes and is not dependent on the growth of the organism, allowing panels to be incubated aerobically without oil overlays, in only 4 hours – saving time and resources. No specialized automation is required, so even small microbiology laboratories can easily adopt RapID.
RapID demonstrates excellent identification of oxidase negative Enterobacteriaceae, anaerobic bacteria, Gram-negative glucose nonfermenters, yeasts and related organisms, streptococci and related organisms, staphylococci and related organisms.
Distinct colour reactions make RapID easy to read and interpret. Accurate identifications are obtained from the user-friendly, Windows®-based ERIC® software, with results ranked by probability.
Watch a video and find out more: www.oxoidhai.com/rapid/
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.